enVVeno Medical (NVNO)
(Delayed Data from NSDQ)
$4.64 USD
-0.10 (-2.11%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $4.59 -0.05 (-1.08%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, enVVeno Medical Corporation has a market cap of $91.23M, which represents its share price of $4.74 multiplied by its outstanding shares number of 19.25M. As a small-cap company, NVNO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NVNO 4.64 -0.10(-2.11%)
Will NVNO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVNO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVNO
NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain
NVNO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NVNO
Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective ...
enVVeno Medical announces findings from health economic study of VenoValve
Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency
enVVeno Medical (NVNO) Eyes Future with VenoValve Approval
enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to ...